Prostate Cancer - Results from #23640

Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: Model estimates of potential benefits and harms - Abstract March 13, 2013

Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancer - Abstract March 13, 2013

Measuring symptoms in localized prostate cancer: A systematic review of assessment instruments - Abstract March 13, 2013

Monte Carlo simulations and radiation dosimetry measurements of (142)Pr capillary tube-based radioactive implant (CTRI): A new structure for brachytherapy sources - Abstract March 13, 2013

Bone Scan Index: A prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy - Abstract March 13, 2013

Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: The randomised, phase 2 MRC PATCH trial (PR09) - Abstract March 13, 2013

Prostate cancer recurrence after radical prostatectomy: The role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging - Abstract March 12, 2013

A tailored prostate cancer education intervention for low-income African Americans: Impact on knowledge and screening - Abstract March 12, 2013

An elevated serum miR-141 level in patients with bone-metastatic prostate cancer is correlated with more bone lesions - Abstract March 12, 2013

Prostate-specific antigen-negative prostate cancer recurrence? - Abstract March 12, 2013

Iodine-125 seed implantation and deferred transurethral resection of the prostate for patients with lower urinary tract symptoms and localized prostate cancer - Abstract March 12, 2013

Clinicians versus nomogram: Predicting future technetium-99m bone scan positivity in patients with rising prostate-specific antigen after radical prostatectomy for prostate cancer - Abstract March 12, 2013

Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: A multicentric European Study - Abstract March 12, 2013

Is there an association between coronary atherosclerosis and carcinoma of the prostate in men aged 50 years and older? An autopsy and coroner based post-mortem study - Abstract March 12, 2013

Angiogenesis and anti-angiogenic therapy in prostate cancer - Abstract March 12, 2013

Health-related quality of life using intensity-modulated radiation therapy for post-prostatectomy radiotherapy - Abstract March 11, 2013

ACR Appropriateness Criteria Prostate Cancer-pretreatment detection, staging, and surveillance - Abstract March 11, 2013

Complications associated with extraperitoneal robot-assisted radical prostatectomy using the standardized Martin Classification - Abstract March 11, 2013

Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy - Abstract March 11, 2013

Long-term outcomes and toxicity in patients treated with brachytherapy for prostate adenocarcinoma younger than 60 years of age at treatment with minimum 10 years of follow-up - Abstract March 11, 2013

Page 1183 of 1435